These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 38196211)

  • 1. Health Professionals and Pharmacists Awareness and Attitude Towards Counterfeit Medicine.
    Chaudhary S
    J Nepal Health Res Counc; 2023 Dec; 21(2):219-225. PubMed ID: 38196211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perceived Prevalence, Awareness and Attitude towards Counterfeit Medicines among Community Pharmacists of Kathmandu Valley: A Descriptive Cross-sectional Study.
    Kafle S; Jha N; Bhandary S; Ravi Shankar P
    JNMA J Nepal Med Assoc; 2024 Jun; 62(275):427-432. PubMed ID: 39369416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of knowledge, attitude, and practice on substandard and counterfeit pharmaceutical products among pharmacy professionals in Gondar City, North-West Ethiopia.
    Worku MC; Mitku ML; Ayenew W; Limenh LW; Ergena AE; Geremew DT; Bizuneh GK; Tefera BB; Mekonnen BA; Anagaw YK
    Curr Pharm Teach Learn; 2024 Oct; 16(10):102140. PubMed ID: 39002340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health Care Providers' Knowledge, Attitude and Practice Toward Counterfeit Medicines in Mizan-Tepi University Teaching Hospital, South West Ethiopia: A Cross-Sectional Study.
    Siraj J; Gebre A; Shafi M; Birhan A; Ejeta F; Hambisa S
    Inquiry; 2022; 59():469580221108335. PubMed ID: 35942588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Community pharmacists' perceptions, awareness and practices regarding counterfeit medicines: a cross-sectional survey in Alexandria, Egypt.
    Bashir A; Galal S; Ramadan A; Wahdan A; El-Khordagui L
    East Mediterr Health J; 2020 May; 26(5):556-564. PubMed ID: 32538449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacist awareness and views towards counterfeit medicine in Lebanon.
    Sholy L; Gard P; Williams S; MacAdam A
    Int J Pharm Pract; 2018 Jun; 26(3):273-280. PubMed ID: 28833852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Counterfeit medicines in Poland: opinions of primary healthcare physicians, nurses and lay persons.
    Binkowska-Bury M; Januszewicz P; Wolan M; Sobolewski M; Krauze M; Fijalek ZE
    J Clin Nurs; 2013 Feb; 22(3-4):559-68. PubMed ID: 22805373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iranian pharmacists' knowledge, attitude and practice regarding counterfeit drugs.
    Shahverdi S; Hajimiri M; Pourmalek F; Torkamandi H; Gholami K; Hanafi S; Ashrafi Shahmirzadi N; Javadi M
    Iran J Pharm Res; 2012; 11(3):963-8. PubMed ID: 24250525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of community pharmacists' readiness to implement the Falsified Medicines Directive (Directive 2011/62/EC): an English cross-sectional survey with geospatial analysis.
    Barrett R
    BMJ Open; 2020 Jan; 10(1):e033405. PubMed ID: 31924640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Challenges Associated with Addressing Counterfeit Medicines in Nigeria: An Exploration of Pharmacists' Knowledge, Practices, and Perceptions.
    Adigwe OP; Onavbavba G; Wilson DO
    Integr Pharm Res Pract; 2022; 11():177-186. PubMed ID: 36561911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of pharmacists in eliminating counterfeit medicines in Nigeria.
    Adigwe OP
    Front Public Health; 2023; 11():1170929. PubMed ID: 37674683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Counterfeit drugs as a gobal threat to health].
    Golocorbin Kon S; Mikov M
    Med Pregl; 2011; 64(5-6):285-90. PubMed ID: 21789919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What Polish hospital healthcare workers and lay persons know about counterfeit medicine products?
    Binkowska-Bury M; Wolan M; Januszewicz P; Mazur A; Fijalek ZE
    Cent Eur J Public Health; 2012 Dec; 20(4):276-81. PubMed ID: 23441393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Managing Pain in Low Resource Settings: Healthcare Professionals' Knowledge, Attitude and Practice Regarding Pain Management in Western Nepal.
    Thapa P; Kc B; Lee SWH; Dujaili JA; Gyawali S; Mohamed Ibrahim MI; Alrasheedy AA
    J Pain Res; 2022; 15():1587-1599. PubMed ID: 35677698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knowledge, attitude, and practice of pharmacy professionals on generic medicines in Eastern Ethiopia: A cross-sectional study.
    Mohammed AS; Woldekidan NA; Mohammed FA
    PLoS One; 2020; 15(7):e0235205. PubMed ID: 32658918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Community pharmacists' knowledge of substandard and falsified medicines in clinical practice: a cross-sectional survey in Saudi Arabia.
    Bashayr Ali A; Barrett R
    Int J Pharm Pract; 2023 Apr; 31(2):176-182. PubMed ID: 36748987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Counterfeit drug demand: perceptions of policy makers and community pharmacists in Sudan.
    Alfadl AA; Hassali MA; Ibrahim MI
    Res Social Adm Pharm; 2013; 9(3):302-10. PubMed ID: 22835708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of health care professionals' knowledge, attitudes, practices and barriers to pharmacovigilance and adverse drug reaction reporting: A cross-sectional multicentral study.
    Khan Z; Karatas Y; Hamid SM
    PLoS One; 2023; 18(5):e0285811. PubMed ID: 37224133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Counterfeit Healthcare Products: Nepal at a Vulnerable Position.
    Bhandari B; Rayamajhi G
    JNMA J Nepal Med Assoc; 2022 Dec; 60(256):1070-1072. PubMed ID: 36705113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combatting Substandard and Falsified Medicines: Public Awareness and Identification of Counterfeit Medications.
    El-Dahiyat F; Fahelelbom KMS; Jairoun AA; Al-Hemyari SS
    Front Public Health; 2021; 9():754279. PubMed ID: 34765583
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.